Company Founder Ingmar Hoerr Succeeds Daniel Menichella as CEO of CureVac AG

by NASDAQ Market News March 11, 2020

NASDAQ Market News
Click here to email author

Excision BioTherapeutics Announces Data Presentation at CROI from IND-Enabling Non-Human Primate studies of EBT-001, supporting a CRISPR Gene Editing Technology for HIV Elimination

Generex Ii-Key Technology for Development of COVID-19 Vaccine Featured in Media

Ads